Jefferies Financial Group Upgrades Aehr Test Systems (NASDAQ:AEHR) to “Strong-Buy”

Aehr Test Systems (NASDAQ:AEHR) was upgraded by investment analysts at Jefferies Financial Group to a “strong-buy” rating in a research note issued to investors on Thursday,Zacks.com reports.

Other equities analysts have also issued research reports about the company. Weiss Ratings lowered Aehr Test Systems from a “sell (d)” rating to a “sell (e+)” rating in a research note on Wednesday, July 29th. Wall Street Zen upgraded Aehr Test Systems from a “sell” rating to a “hold” rating in a research report on Saturday, July 18th. Lake Street Capital reissued a “buy” rating and set a $110.00 target price on shares of Aehr Test Systems in a report on Wednesday, July 15th. Zacks Research upgraded Aehr Test Systems from a “hold” rating to a “strong-buy” rating in a research report on Friday, July 17th. Finally, Freedom Capital upgraded Aehr Test Systems from a “hold” rating to a “strong-buy” rating in a research report on Thursday, July 16th. Three analysts have rated the stock with a Strong Buy rating, three have issued a Buy rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Buy” and an average price target of $136.67.

Aehr Test Systems Trading Up 8.7%

Shares of AEHR stock opened at $134.06 on Thursday. The stock has a market cap of $4.37 billion, a P/E ratio of -558.56 and a beta of 3.10. The stock has a 50 day simple moving average of $92.83 and a 200 day simple moving average of $71.45. Aehr Test Systems has a 1 year low of $16.38 and a 1 year high of $147.40.

Insider Buying and Selling at Aehr Test Systems

In related news, Director Howard T. Slayen sold 5,700 shares of the firm’s stock in a transaction dated Friday, August 14th. The stock was sold at an average price of $133.03, for a total value of $758,271.00. Following the sale, the director directly owned 140,667 shares of the company’s stock, valued at $18,712,931.01. This trade represents a 3.89% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, Director Laura Oliphant sold 1,717 shares of the firm’s stock in a transaction dated Wednesday, August 12th. The shares were sold at an average price of $133.00, for a total value of $228,361.00. Following the completion of the sale, the director directly owned 16,100 shares in the company, valued at $2,141,300. This trade represents a 9.64% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 109,475 shares of company stock worth $13,827,160 over the last quarter. 6.80% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On Aehr Test Systems

Several hedge funds and other institutional investors have recently made changes to their positions in AEHR. Royal Bank of Canada increased its position in Aehr Test Systems by 262.7% during the 1st quarter. Royal Bank of Canada now owns 50,207 shares of the semiconductor company’s stock worth $365,000 after purchasing an additional 36,364 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its position in Aehr Test Systems by 8.5% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 17,225 shares of the semiconductor company’s stock valued at $126,000 after buying an additional 1,344 shares in the last quarter. JPMorgan Chase & Co. raised its holdings in Aehr Test Systems by 7.9% in the 2nd quarter. JPMorgan Chase & Co. now owns 15,576 shares of the semiconductor company’s stock valued at $201,000 after buying an additional 1,145 shares during the last quarter. Legal & General Group Plc boosted its position in Aehr Test Systems by 110.8% during the 2nd quarter. Legal & General Group Plc now owns 6,882 shares of the semiconductor company’s stock worth $89,000 after buying an additional 3,617 shares during the period. Finally, Rhumbline Advisers boosted its position in Aehr Test Systems by 3.1% during the 2nd quarter. Rhumbline Advisers now owns 41,466 shares of the semiconductor company’s stock worth $536,000 after buying an additional 1,254 shares during the period. 69.69% of the stock is owned by institutional investors.

Trending Headlines about Aehr Test Systems

Here are the key news stories impacting Aehr Test Systems this week:

• Positive Sentiment: Jefferies initiated coverage with a bullish view, helping drive renewed investor interest. The analyst reportedly described the price target as conservative and identified additional potential catalysts that were not included in the model. Jefferies Initiates Coverage on Aehr Test Systems
• Positive Sentiment: Aehr received a $22 million follow-on order from its lead customer for wafer-level burn-in systems used with advanced AI training and inference processors. The repeat business supports demand for the company’s FOX systems and strengthens its position in AI and high-performance computing. Aehr Receives $22 Million Follow-on Order
• Positive Sentiment: Recent company updates pointed to record quarterly bookings of $60.7 million, a backlog of approximately $100.6 million and fiscal 2027 revenue guidance of $130 million to $150 million. These figures provide revenue visibility and support the investment case tied to rising AI-chip testing demand. Aehr AI Order and WLBI Opportunity
• Neutral Sentiment: CEO Gayn Erickson and CFO Chris Siu will meet investors at the Needham Virtual Semiconductor and SemiCap 1×1 Conference on August 19. The event could provide further commentary on backlog conversion and fiscal 2027 execution, but no new financial information was announced. Aehr to Participate in Needham Conference
• Negative Sentiment: Several insiders sold shares after AEHR’s sharp rally. The transactions included the CEO’s sale of 40,000 shares for about $5.2 million, the COO’s sale of 15,000 shares for roughly $2.0 million, and additional director and executive sales. Although insiders retained sizable positions—and the CEO sale came from a trust—such activity may signal profit-taking and add selling pressure. Aehr CEO Share Sale
• Negative Sentiment: One analyst began coverage on a bearish note, highlighting the risk that expectations have become difficult to meet after the stock’s extraordinary advance. AEHR’s elevated valuation and dependence on continued AI order growth leave it vulnerable if bookings, backlog conversion or execution disappoints. Bearish Analyst Initiation

About Aehr Test Systems

Aehr Test Systems develops, manufactures and sells semiconductor test and burn-in equipment used by device manufacturers to ensure quality and reliability of integrated circuits. Its products are designed for wafer-level reliability assessment, functional test and stress screening of memory devices, system-on-chips, optical components and power semiconductors. By focusing on wafer-level burn-in and testing processes, the company helps reduce cost and improve yield for high-volume semiconductor production.

The company’s product portfolio includes FOX series wafer probe test and burn-in systems as well as ABTS burn-in ovens.